The Infusion Management Software segmentation by application distinguishes four primary use‑cases that together shape the market’s revenue composition. Hospital infusion systems dominate, accounting for roughly 55 % of total sales, driven by large‑scale IV therapy units, centralized medication safety workflows, and integration with electronic health records. Home infusion solutions represent about 25 % as payers shift toward outpatient care; these platforms emphasize remote monitoring, patient‑centric dosing alerts, and compliance tracking. Ambulatory care centers, contributing near 15 %, focus on short‑stay clinics and infusion suites where rapid turnover and point‑of‑care analytics are critical. Finally, oncology specialty sites hold the remaining 5 %, characterized by high‑precision dosing, complex regimen management, and tight regulatory reporting. Each segment’s share reflects its operational complexity, volume of infusions processed, and the degree of software‑enabled automation, collectively defining the overall market size.